<DOC>
	<DOCNO>NCT02307539</DOCNO>
	<brief_summary>This pilot clinical trial study palliative care program improving quality life patient newly diagnose pancreatic cancer . Palliative care care give patient serious life-threatening disease , focus manage disease symptom , side effect treatment disease , improve patient quality life . Studying palliative care program use type cancer may help doctor learn whether improve quality life patient pancreatic cancer .</brief_summary>
	<brief_title>Palliative Care Improving Quality Life Patients With Newly Diagnosed Pancreatic Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To pilot-test interdisciplinary Palliative Care Planning Intervention ( PCPI ) pancreatic cancer . Specifically , describe patient ' satisfaction timing , content , delivery PCPI intervention . SECONDARY OBJECTIVES : I . To pilot-test select measure study , include measure healthcare resource utilization , overall cost , patient/family pocket expense . II . The long-term objective pilot study conduct large PCPI intervention study pancreatic cancer patient evaluate impact quality life ( QOL ) , symptom intensity , healthcare resource utilization , healthcare cost . OUTLINE : Patients receive handbook title `` Supporting You During Cancer Treatment '' educational material QOL issue . Patients undergo 2 education session handbook material in-person telephone , session 1 focus physical social well-being issue session 2 focus psychological spiritual well-being issue . At begin session , patient select 3 priority topic list , content tailor patient need . After completion study , patient follow 1 2 month .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Pathologically confirm , new diagnosis borderline resectable , locally advance resectable/unresectable , metastatic pancreatic cancer Patients schedule receive treatment ( neoadjuvant therapy , surgery , adjuvant therapy , palliative chemotherapy ) City Hope ( COH ) All subject must ability understand willingness provide inform consent Subjects , opinion investigator , may able comply safety monitoring requirement study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>